Ligand-based adoptive T cell targeting CA125 in ovarian cancer

BACKGROUND: Ovarian cancer (OC) is a highly aggressive gynecological malignancy prevalent worldwide. Most OC cases are typically diagnosed at advanced stages, which has led to a 5-year overall survival rate of less than 35% following conventional treatment. Furthermore, immune checkpoint inhibitor t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Haihong, Wu, Lina, Dai, Jiemin, Sun, Ke, Zi, Zhenguo, Guan, Junhua, Zhang, Liwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481596/
https://www.ncbi.nlm.nih.gov/pubmed/37670338
http://dx.doi.org/10.1186/s12967-023-04271-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481596/
https://www.ncbi.nlm.nih.gov/pubmed/37670338
http://dx.doi.org/10.1186/s12967-023-04271-8

Ejemplares similares